Cargando…

Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers

The evaluation of thrombotic and pregnancy risks associated with antiphospholipid antibodies (aPL)in individual patients without antiphospholipid syndrome (APS) clinical manifestation is challenging. Our aim is to identify additional risk factors or potential candidate “second hits” for APS clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Yu, Fan, Jennifer, Sarode, Ravi, Zhang, Song, Makris, Una E., Karp, David R., Shen, Yu-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714722/ https://www.ncbi.nlm.nih.gov/pubmed/29471673 http://dx.doi.org/10.1177/1076029618755946

Ejemplares similares

Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients
por: Li, Chun, et al.
Publicado: (2022)

Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis
por: Mialdea, Maria, et al.
Publicado: (2009)

Risk of Thrombosis, Pregnancy Morbidity or Death in Antiphospholipid Syndrome
por: Killian, Martin, et al.
Publicado: (2022)

Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003)

Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis
por: Mineo, Chieko, et al.
Publicado: (2016)

Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy
por: Rodríguez, Carlos M., et al.
Publicado: (2021)

LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers
por: Ochoa, Eguzkine, et al.
Publicado: (2016)

302. Using Antiphospholipid Antibody Presence as an Additional Biomarker to Identify COVID-19 Positive Patients with High Risk for Thrombosis
por: Hewlett, Jennifer R, et al.
Publicado: (2021)

ARTERIAL THROMBOSIS IN COVID 19 AND ANTIPHOSPHOLIPID ANTIBODIES
por: Elhouderi, Eiman, et al.
Publicado: (2021)

Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
por: Dambrauskienė, Rūta, et al.
Publicado: (2023)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
por: Lee, Eunyoung Emily, et al.
Publicado: (2021)

Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers
por: Calcaterra, Ilenia, et al.
Publicado: (2021)

Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
por: Nalli, Cecilia, et al.
Publicado: (2021)

Loss of antiphospholipid antibody positivity post-thrombosis in SLE
por: Khawaja, Muznay, et al.
Publicado: (2020)

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers
por: Roggenbuck, Dirk, et al.
Publicado: (2016)

Antiphospholipid antibodies in patients with upper-extremity deep vein thrombosis
por: Nikolova-Vlahova, Milena K., et al.
Publicado: (2015)

Simultaneous Occurrence of Deep Vein Thrombosis and Carotid Artery Thrombosis in Antiphospholipid Antibody Syndrome
por: Mahale, Rohan R., et al.
Publicado: (2017)

Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome
por: Alvarez, Angela M., et al.
Publicado: (2017)

Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events
por: Zuo, Yu, et al.
Publicado: (2023)

Effects of anti‐beta 2‐glycoprotein 1 antibodies and its association with pregnancy‐related morbidity in antiphospholipid syndrome
por: Fierro, Juan J., et al.
Publicado: (2021)

Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19
por: Cimolai, Nevio
Publicado: (2021)

Associations of Antiphospholipid Antibodies With Splanchnic Vein Thrombosis: A Systematic Review With Meta-Analysis
por: Qi, Xingshun, et al.
Publicado: (2015)

Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies
por: Lazzaroni, Maria-Grazia, et al.
Publicado: (2019)

Bouquet variety of antiphospholipid antibodies in recurrent pregnancy loss
por: Baleva, Marta P., et al.
Publicado: (2014)

COVID-19, Antiphospholipid Syndrome and Thrombosis
por: Yasri, Sora, et al.
Publicado: (2020)

Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022)

Coronary Artery Thromboses, Stent Thrombosis and Antiphospholipid Antibody Syndrome: Case Report
por: Correia, Augusto Ferreira, et al.
Publicado: (2018)

Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching
por: Oba, Seiya, et al.
Publicado: (2023)

Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)

Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2021)

Deep cerebral venous sinus thrombosis with transient antiphospholipid antibodies in COVID-19 disease
por: Loos, C. M. J., et al.
Publicado: (2021)

Antiphospholipid immune complexes as thrombosis risk marker
por: Martínez-Flores, José A., et al.
Publicado: (2019)

Antiphospholipid antibody‐activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome
por: Lu, Yuan, et al.
Publicado: (2020)

Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers
por: Lin, Ting-Syuan, et al.
Publicado: (2017)

Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study
por: Del Barrio-Longarela, Sara, et al.
Publicado: (2021)

Antiphospholipid Syndrome and Antibodies
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2014)

Chorea Associated with High Titers of Antiphospholipid Antibodies in the Absence of Antiphospholipid Antibody Syndrome
por: Safarpour, Damoun, et al.
Publicado: (2015)

Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study
por: Million, Matthieu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vj85vchca5g36sbo2rv9phmn82